Lijuan Cui

1.5k citations
44 papers · 869 indexed · 1 hit paper · h-index 15
Topics
Receptor Mechanisms and Signaling (6 papers)Pancreatic function and diabetes (5 papers)MicroRNA in disease regulation (3 papers)

In The Last Decade

Lijuan Cui

42 papers receiving 851 citations

Hit Papers

GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects2021202620222024202150100150200250

Peers

Lijuan Cui
Comparison fields: 5 of 113
  • Molecular Biology 371
  • Endocrinology, Diabetes and Metabolism 235
  • Surgery 146
  • Cancer Research 122
  • Oncology 117
Replace Eijiro Yamada with:
Eijiro Yamada Japan
Darya Zibrova Germany
Bo Dong China
Carol Wadham Australia
Shogo Kurebayashi Japan
Manyu Luo China
Anne‐Laure Guihot France
Soghra Fatima United States
Richard K. Plante Canada
Su Xu United Kingdom
Lijuan Cui relative to Eijiro Yamada Japan Eijiro Yamada's profile →
Citations per field
00.5×
Eijiro Yamada · 1×
Citations per year

Countries citing papers authored by Lijuan Cui

Since Specialization
Citations

This map shows the geographic impact of Lijuan Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lijuan Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lijuan Cui more than expected).

Fields of papers citing papers by Lijuan Cui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lijuan Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lijuan Cui. The network helps show where Lijuan Cui may publish in the future.

Co-authorship network of co-authors of Lijuan Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Lijuan Cui. A scholar is included among the top collaborators of Lijuan Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lijuan Cui. Lijuan Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 2
3 2
4 0
5 2
6 6
7 8
8 4
9 8
10 3
11 57
12 5
13 35
14 16
15 3
16 55
17 5
18 23
19 11
20 21

About Lijuan Cui

Lijuan Cui is a scholar working on Cancer Research, Molecular Biology and Pathology and Forensic Medicine, having authored 44 papers that have together received 869 indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (6 papers), Pancreatic function and diabetes (5 papers) and MicroRNA in disease regulation (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (235 citations), Cancer Research (122 citations) and Molecular Biology (371 citations). Lijuan Cui has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Yunfeng Liu, Yi Zhang, Huan Xue, Zhihong Lu, Minghe Wang, Chao Fu, Xin Zhao, Mingsheng Zhang, Xiaomin Hou and Song Jun-mei. Their work appears in journals such as Blood, Scientific Reports and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026